Clinical outcomes of nirmatrelvir-ritonavir use in pregnant women during the Omicron wave of the coronavirus disease 2019 pandemic

• Main Authors: Chih-Wei Lin (Author), Yu-Ling Liang (Author), Ming-Ta Chuang (Author), Chun-Han Tseng (Author), Pei-Yin Tsai (Author), Mei-Tsz Su (Author)
• Format: Book
• Published: Elsevier, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Paxlovid is an oral drug composed of nirmatrelvir and ritonavir that has been demonstrated to be effective in decreasing the risk of severe coronavirus disease 2019 (COVID-19). Here, we report the use of paxlovid in pregnant women with COVID-19. Methods: Pregnant women attending a tertia...